Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Metastatic Breast Cancer|Breast Neoplasm|Breast Cancer Metastatic|End Stage Cancer
Interventions: BIOLOGICAL: SV-BR-1-GM|DRUG: Cyclophosphamide|DRUG: Interferon infiltration of the inoculation site|DRUG: Retifanlimab|DRUG: Treatment of Physician's Choice
Sponsor: BriaCell Therapeutics Corporation